2 ASX shares to buy now at bargain prices that you've forgotten about

There are many cheap stocks currently out there to consider. Here's a pair you might not have on your radar.

| More on:
A man looks surprised as a woman whispers in his ear.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Wise long-term investors will have been using this year's depressed market to snap up some bargains.

However, when the whole market is so down in the dumps, you can't possibly keep track of all the cheapies out there.

That's why it's worth listening to some experts who have spotted some excellent candidates:

18% share price upside while interest rates head up

With interest rates looking very likely to rise this year, finance and insurance ASX shares have already been tipped by many analysts as value plays.

But one name that hasn't popped up too much is Challenger Ltd (ASX: CGF).

The annuities and income funds provider is a buy in Morgans investment advisor Jabin Hallihan's book at the moment.

"A key feature of these products is they distribute cash flow and protect against market movements and inflation risks," he told The Bull.

"Such products appeal for their stability, particularly during times of market volatility."

The stock could potentially be at an attractive entry point right now, having fallen more than 4% this year so far.

Hallihan's team has a 12-month price target of $7.74, which is an 18% upside.

Challenger shares also return a handy dividend yield of around 3.35%.

Australians need healthcare, regardless of what else is happening

Healthcare is one of those sectors that is somewhat resistant to economic and interest rate cycles. People will always need to take care of their health.

As such, Wilsons investment advisor Peter Moran would currently buy shares in Integral Diagnostics Ltd (ASX: IDX).

"This diagnostic imaging services company recently undertook a $90 million capital raising to fund the acquisition of Peloton Radiology."

The Integral share price has fallen close to 23% so far this year.

Moran admitted February financials were not favourable, but expected the underperformance to be temporary.

"First half 2022 operating net profit after tax was down 21.7% on the prior corresponding period," he said.

"The result was impacted by COVID-19 restrictions. However, with restrictions easing, we expect profitability to recover as margins improve and recent investments in their business start to produce a return."

Moran's team holds an overweight recommendation on Integral shares.

The stock is somewhat polarising, with CMC Markets showing 6 of 13 analysts rating it as a strong buy while 5 label it as a hold.

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Challenger Limited and Integral Diagnostics Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Up 110% in 12 months: Why this ASX 200 stock can keep flying

Let's see what Bell Potter is saying about this high-flyer.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A man in a dark blue suit walks through an airport past floor-to-ceiling windows with a Qantas plane flying in the distance
Travel Shares

Up 16% this year, does Macquarie rate Corporate Travel Management shares a buy, hold or sell?

Does the travel stock have further to fly?

Read more »

group of friends checking facebook on their smartphones
Broker Notes

Macquarie tips 22% return for this ASX telco stock

This telco could be undervalued at current levels according to the broker.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A mature age woman with a groovy short haircut and glasses, sits at her computer, pen in hand thinking about information she is seeing on the screen.
Broker Notes

Passive income: What's CBA's dividend outlook according to Macquarie?

Is CBA still a top passive income stock?

Read more »

A smiling woman looks at her phone as she walks with her suitcase inside an airport.
Broker Notes

Down 41% in a year, why Macquarie thinks Flight Centre shares are set to rebound

Is Flight Centre about to take off?

Read more »

A group of miners in hard hats sitting in a mine chatting on a break as ASX coal shares perform well today
Broker Notes

Does Macquarie rate Liontown Resources shares a buy, hold or sell?

Let’s find out what the broker had to say.

Read more »